This inventor holds 2 USPTO granted patents. Top assignee: The State University of New York. Active years: 2008-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2010
Title: The Innovative Contributions of Hesham Nawar
Introduction
Hesham Nawar is a notable inventor based in Buffalo, NY (US). He has made significant contributions to the field of immunology through his innovative research and inventions. With a total of 2 patents, Nawar's work focuses on enhancing immune responses to antigens.
Latest Patents
Nawar's latest patents include groundbreaking research on the adjuvant activities of mutants of LT-IIa and LT-IIb enterotoxin lacking binding to ganglioside. The first patent describes the adjuvant activity of these mutants, specifically highlighting that the LT-IIb(T13I) mutant exhibits comparable adjuvant activity to the wild type LT-IIb. Additionally, the LT-IIa(T34I) mutant is noted for its late onset adjuvant activity. These innovations are crucial for improving immune responses, making them valuable in the field of vaccine development.
Career Highlights
Hesham Nawar is affiliated with the State University of New York, where he conducts his research and develops his inventions. His work has garnered attention for its potential applications in enhancing vaccine efficacy and immune response.
Collaborations
Nawar collaborates with esteemed colleagues such as Terry D Connell and Michael W Russell, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Hesham Nawar's contributions to immunology through his patents and research are significant. His work not only advances scientific understanding but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile